Correlation between multi-drug resisitance and Her-2 gene in breast cancer
10.3760/cma.j.issn.1006-9801.2012.04.005
- VernacularTitle:乳腺癌多药耐药与Her-2基因表达的相关性研究
- Author:
Jie CHAI
;
Xuezhen MA
- Publication Type:Journal Article
- Keywords:
Breast neoplasms;
Multidrug resistance-associated proteins;
Genes,erbB-2;
In situ hybridization,fluorescence;
Immunohistochemistry
- From:
Cancer Research and Clinic
2012;24(4):232-234
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the correlation between the expression of p170、GST-π 、TOPO Ⅱ and the expression of Her-2 in human breast cancer. Methods The expression of Her-2 was detected by fluorescence in situ hybridization.The expression of p170,GST-π,TOPO Ⅱ were tested in 48 breast cancer by immunohistochemical SP method,and their correlations with clinicopathological features and the expression of Her-2 were analyzed.Results The positive rate of p170,GST-π,TOPO Ⅱ were 43.8 ％(21/48),39.6 ％(19/48),56.3 ％(27/48),respectively. The expression of p170, GST-π,TOPO Ⅱ positively correlated with the expression of Her-2(P＜ 0.05).The levels of p170,GST-π,TOPO Ⅱ expression were not associated with age,primary tumor and lymph node metastasis(P ＞ 0.05).Conclusion There is great possibility of chemotherapy drug resistance in breast cancer with expression of Her-2.Expressions of p170,GST-π,TOPO Ⅱ and Her-2 have an instructive significance for chemotherapy.
